Yahoo Malaysia Web Search

Search results

  1. Feb 6, 2024 · 301-846-5954. Joel.Schneider@ nih.gov. Research Topics. Our group develops novel materials for use in the delivery of therapeutics and as antibacterial agents. We are particularly interested in peptide and protein-based hydrogel materials formed by self-assembly mechanisms.

  2. Articles 1–20. ‪National Cancer Institute‬ - ‪‪Cited by 16,468‬‬ - ‪soft materials‬ - ‪drug delivery‬ - ‪self-assembly‬ - ‪cell-penetrating peptides‬ - ‪peptide design synthesis &...

  3. Chemical Biology Laboratory. Senior Investigator. Head, Peptide Design and Materials Section. CCR Deputy Director. RESEARCH SUMMARY. The Schneider group designs and characterizes novel materials for use in drug delivery, the delivery of cells, and antibacterial therapy. Areas of Expertise. Cancer Drug Discovery. Soft Materials. Drug Delivery.

  4. Joel P. Schneider. Broad size distributions and poor long‐term colloidal stability of microRNA‐carrying nanoparticles, especially those formed by polyelectrolyte complexation, represent major...

  5. Selective Bibliography of Dr. Joel Schneider. Chemical Biology Laboratory, NCI. "" Wednesday, May 25, 2022. 1. Nambiar M, Schneider JP. Peptide hydrogels for affinity-controlled release of therapeutic cargo: Current and potential strategies. Journal of Peptide Science 28 (1):e3377 Jan 2022. 2.

  6. Education. Show more detail. Source : Joel Schneider. expand_more. Works (10) sort Sort. Electrical resistance of the current collector controls lithium morphology. Nature Communications. 2022-07-09 | Journal article | Author. DOI: 10.1038/s41467-022-31507-w. Part of ISSN: 2041-1723.

  7. Joel Schneider. Dr. Joel Schneider received his B.Sc. in chemistry at the University of Akron in 1991 before moving to Texas A&M University for a Ph.D. in chemistry developing beta-sheet peptide mimetics to study the mechanisms leading to amyloid formation.